Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation

Adv Cancer Res. 1983:40:255-329. doi: 10.1016/s0065-230x(08)60682-x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aclarubicin* / analogs & derivatives*
  • Acute Disease
  • Adolescent
  • Adult
  • Age Factors
  • Aminoacridines / therapeutic use
  • Amsacrine
  • Anthraquinones / therapeutic use
  • Antibodies, Monoclonal
  • Azacitidine / therapeutic use
  • Bone Marrow Transplantation*
  • Child
  • Child, Preschool
  • Drug Administration Schedule
  • Etoposide / therapeutic use
  • Humans
  • Ifosfamide / therapeutic use
  • Immunotherapy
  • Infant
  • Interferons / therapeutic use
  • Leukemia / mortality
  • Leukemia / therapy*
  • Leukemia, Lymphoid / therapy
  • Liposomes / administration & dosage
  • Middle Aged
  • Mitoxantrone
  • Naphthacenes / therapeutic use
  • Prognosis
  • Teniposide / therapeutic use
  • Transplantation, Homologous
  • Transplantation, Isogeneic
  • Vinblastine / analogs & derivatives
  • Vinblastine / therapeutic use
  • Vindesine

Substances

  • Aminoacridines
  • Anthraquinones
  • Antibodies, Monoclonal
  • Liposomes
  • Naphthacenes
  • aclacinomycins
  • Amsacrine
  • Vinblastine
  • Etoposide
  • Aclarubicin
  • Interferons
  • Teniposide
  • Mitoxantrone
  • Azacitidine
  • Vindesine
  • Ifosfamide